申请人:——
公开号:US20020091150A1
公开(公告)日:2002-07-11
The present invention is a compound of formula
1
wherein R
1
, R
2
, R
2′
, X, A
1
/A
2
and B are as defined in the specification.
These compounds may be used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia caused by pregnancy, cardiac arrest, hypoglycaemia, Alzheimer's disease, Huntington's chorea, ALS, dementia caused by AIDS, eye injuries, retinopathy, cognitive disorders, memory deficits, schizophrenia, idiopathic parkinsonism or parkinsonism caused by medicaments as well as conditions which lead to glutamate deficiency functions, such as e.g. muscle spasms, convulsions, migraine, urinary incontinence, nicotine addiction, psychoses, opiate addiction, anxiety, vomiting, acute and chronic pain, dyskinesia and depression.
本发明涉及一种化合物,其化学式为1,其中R1,R2,R2',X,A1 / A2和B如规范中所定义。这些化合物可用于控制或预防急性和/或慢性神经系统疾病,例如由旁路手术或移植引起的受限脑功能,脑血供不足,脊髓损伤,头部损伤,妊娠引起的缺氧,心脏骤停,低血糖,阿尔茨海默病,亨廷顿病,肌萎缩侧索硬化症,由艾滋病引起的痴呆,眼部损伤,视网膜病变,认知障碍,记忆障碍,精神分裂症,特发性帕金森病或药物引起的帕金森病,以及导致谷氨酸缺乏功能的情况,例如肌肉痉挛,惊厥,偏头痛,尿失禁,尼古丁成瘾,精神病,鸦片成瘾,焦虑,呕吐,急性和慢性疼痛,运动障碍和抑郁症。